Kennedy Institute of Ethics Journal 29 (4):305-331 (2020)

In phase I clinical trials, healthy volunteers are dosed with investigational drugs and subjected to blood draws and other bodily monitoring procedures. In exchange, they are paid. Healthy volunteers are, in a very direct sense, selling access to their bodies for pharmaceutical companies and their associates to run drugs through. In his ethnographic study of socalled professional guinea pigs, Roberto Abadie writes, "Paid volunteers are well aware of the demand for an idealized, perfectly healthy volunteer. They also realize that their body is a valued commodity in clinical trials research". It is perhaps surprising, then, that commodification is little discussed in the bioethics literature on phase I...
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1353/ken.2019.0028
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 60,021
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Healthy Children as Subjects in Pharmaceutical Research.Gideon Koren - 2003 - Theoretical Medicine and Bioethics 24 (2):149-159.


Added to PP index

Total views
8 ( #961,187 of 2,433,464 )

Recent downloads (6 months)
1 ( #468,801 of 2,433,464 )

How can I increase my downloads?


My notes